Daewoong unveils new liquefied-form analgesic

Published: 2006-12-01 06:56:00

Updated: 2006-12-01 06:56:00

Daewoong Pharm rolled out a new liquefied-form analgesic EGN6 containing dexibuprofen, a non-steroidal anti-inflammatory (NSAID), analgesic, and antipyretic (fever reducing) drug.

Dexibuprofen is also known as (S)-(+)-2-(4-isobutylphenyl)propionic acid or (S)-ibuprofen. It is practically insol...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK